ISIS Pharmaceuticals, Inc. (ISIS)

All Comments on ISIS

  • commenter
    John Egan
    May 04 09:09 PM
    Isis Pharmaceuticals Panic Overdone [view article]
    "J.G. Rollander"... Well, I'm hazarding a guess, but I expect anyone on Alpha is actually intent on making money and not losing it.... Just like Warren Buffett says..I doubt that there's a lot of altruism or 'hope for the future of mankind' in most investor's hearts..

    Thx jegan ;-)     Reply
  • commenter
    J.G.
    Rollander
    Apr 30 12:54 PM
    Isis Pharmaceuticals Panic Overdone [view article]
    Re ISIS: It is amazing to watch people writhe around in analysis mode when there is severe price movement in a stock, especially a stock built around substantive goals, like ISIS...and it always tends to identify the writer as to why he is buying the stock at all. Is he a quick buck person, or an investor, or a long term investor who believes in the goals of a responsible company that is interested in all the activity, including temporary setbacks, but who would not consider selling out of fear or saving himself from some perceived disaster. Please..take the time to look at ISIS History. True it has had its false starts..temporary setbacks, disappointing frustrations, but it is out to do something worthwhile, and so you need to be an investor...or at least someone who buys this stock for the RIGHT reasons, to feel its pulse and know that you are involved in a brilliant, honest, and forward-looking, multi-faceted Company who one day soon will be looked upon as a rare exemplar in the industry. Reply
  • commenter
    www.evergree
    n.org
    Apr 28 02:54 PM
    My Website
    Isis Pharmaceuticals Panic Overdone [view article]
    The author is unaware of less than you. IBIS is owned by ISIS. Reply
  • commenter
    Cherrypicker
    Apr 28 11:54 AM
    Isis Pharmaceuticals Panic Overdone [view article]
    What does IBIS (i.e. the Abbott Labs potential deal mentioned) have to do with ISIS? The author says he is unaware of a lot, but surely he knows the difference between the two companies? Reply
  • commenter
    Ben Around
    Apr 26 08:40 AM
    Isis Pharmaceuticals Panic Overdone [view article]
    I agree with the writer. Overreaction has opened a buying opportunity.

    Bought it at 11.5 sold at 16 and now will buy it again next week,

    It looks like ISIS is a range stock that moves between these limits untill some blockbuster deal is announced

    So I will not fight it, I will just buy again.

    Reply
  • commenter
    BioInvestor
    Apr 26 05:42 AM
    My Website
    Isis Pharmaceuticals Panic Overdone [view article]
    Isis certainly has a formidable patent position. The company has a large effort into securing intellectual property in this area. The big issue is in ensuring an effective delivery system--something which, at one point, monoclonal antibody products had to face. Now, monoclonal antibody products are moving rapidly through the development/approval process. It's frankly only a matter of time until antisense products reach the market. Isis is in a very strong position in this technology and should be a long-term winner. Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:20 AM
    My Website
    General Discussion on ISIS
    Is this a buy or a sell? Reply
  • commenter
    Ryan
    Feb 07 07:59 PM
    My Website
    Isis-Genzyme: Deal of the Year? [view article]
    Agreed, Mardez. I'm sticking with it.

    Regards,
    Ryan Freund
    freundinvesting.com     Reply
  • commenter
    mardez678
    Feb 07 02:46 PM
    Isis-Genzyme: Deal of the Year? [view article]
    Company insiders are allowed to buy stock only within a very narrowly defined time frame per SEC rules because they are privy to insider information.

    When you invest in Biotech you must have a ten year, or more, time frame. This is about the time it takes for a drug to get to market - if at all.

    ISIS is the first biotech drug I have ever invested in and I did so because of the science. It is innovative and looks at an aspect of our DNA/RNA makeup that reveals a potential to stop disease by stopping or turning off certain protein production functions specific to a certain disease and thereby preventing or stopping the disease.

    Who else beleives that they can do this?

    These companies: EI Lilly, Alnylam, Ortho-Mcneil, Bristol Myers Squibb, J & J, Pfizer, Achaogen, Merck & Co., Antisense Therapeutics, Atlantic, Healthcare(UK), iCO, ImQuest Pharmaceuticals, OncoGenex, Sarissa, Archemix, Ercole Biotec, Rosetta Genomics, Santaris Pharma, Idera Pharma, Integrated DNA Tech., Drug Royalty USA, Inc., Eyetech Pharma and finally there is IBIS, which manufactures the T5000, which can identify bacteria and virus in human clinical samples and give an antidote or a cure in a few hours. This last was essentially purchased by Abbott last month.

    Should you own ISIS - only if you have patience and the willingness to stick with a formidable bio-tech company that has cutting edge technology to cure and prevent disease from opthalmic to cancer.

    Disclosure: writer has common and call options on ISIS.
    Reply
  • commenter
    Promod
    Radhakrishna
    n
    Feb 05 08:34 AM
    My Website
    A Volatile January for Financials, Healthcare [view article]
    sun rising: Sorry, didn't see your question. Now that the event's over, i hope you did exit. Oil this year might not have a good run. Reply
  • commenter
    sunrises
    Jan 31 02:58 PM
    A Volatile January for Financials, Healthcare [view article]
    is it advisable to sell cvx at 2-3% loss prior to earning report? Reply
  • commenter
    Ryan
    Jan 28 09:45 PM
    My Website
    Isis-Genzyme: Deal of the Year? [view article]
    Isis wasn't getting these kinds of deals back then... I believe it's a good idea to at least hold a small position. Reply
  • commenter
    Jay Ell
    Jan 28 08:33 PM
    Isis-Genzyme: Deal of the Year? [view article]
    When I first bought Isis stock about 20yrs ago, it was on the basis of the company having the potential of being another Microsoft. OK, so even if it were only half the hype, that wouldn't be so bad. Nothing ever happened so I sold the stock last year.
    Do I buy back in or is this another pipe dream?

    Reply
  • commenter
    Ryan Freund
    Jan 28 01:49 PM
    My Website
    Isis-Genzyme: Deal of the Year? [view article]
    Is that true for the rest of the Isis team? I would like to see all of them buying stock. Reply
  • commenter
    GEORGE1
    Jan 28 11:54 AM
    Isis-Genzyme: Deal of the Year? [view article]
    ALSO SAYS HE ALREADY HAS 2000000 SHARES NOW..WAS NOT HAPPY WITH MY COMMENT Reply
Loading...
Symbols:
Authors:
Quick Links: